Transcription of FARAD Digest
{{id}} {{{paragraph}}}
JAVMA, Vol 223, No. 9, November 1, 2003 Vet Med Today: FARAD Digest1277 Recently published pharmacokinetic studies andnew drug approvals have made it possible and nec-essary to update the previously published FoodAnimal Residue Avoidance Databank ( FARAD )extralabel withdrawal interval (WDI)recommenda-tions for pharmaceuticals administered to food-pro-ducing animals. A label withdrawal time (WDT)isestablished by the FDA Center for Veterinary Medicinewhen a drug is approved for use in a food to the label WDT ensures that tissues orproducts taken from the treated animal will not con-tain residues in excess of the official WDIs are a specific FARAD recommenda-tion delineating the withholding time necessary toensure that violative residues of a drug will not bedetectable in tissues or products following extralabeluse. FARAD recommendations for WDIs are based onpharmacokinetic data analysis, foreign and domesticlabel WDTs, and maximum residue limits (MRLs).
1278 Vet Med Today: FARAD Digest JAVMA, Vol 223, No. 9, November 1, 2003 These milk WDIs apply only to aqueous formulations of oxytetracycline.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}